← All diseases Heart and blood vessels

Cardiac amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (41)Meta-analysis (6)Treatment guideline (1)Phase 3 study (19)Systematic review (12)Randomized Controlled Trial (3)Clinical trial (374)Review article (176)Early study (phase 1 or 2) (7)Case report (199)Laboratory or animal study (2)Commentary or Editorial (86) Studies currently recruiting participants only (37)

Filter

Publications and studies (1416)

• Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. (2021/04/01) ♡
• Acute exposure to C60 fullerene damages pulmonary mitochondrial function and mechanics. (2021/04/01) ♡
• Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis. (2021/04/01) ♡
• Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis. (2021/03/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Left Ventricular Mass-To-Strain Ratio Predicts Cardiac Amyloid Subtype. (2021/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coexistence of amyloidosis and light chain deposition disease in the heart. (2021/03/01) ♡
• Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis? (2021/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Prediction of Incident Heart Failure in TTR Val122Ile Carriers One Year Ahead of Diagnosis in a Multiethnic Biobank. (2021/03/01) ♡
• Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. (2021/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treatment Response Evaluation of Cardiac Amyloidosis Using Serial T1- and T2-Mapping Cardiovascular Magnetic Resonance Imaging. (2021/03/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). (2021/02/15) ♡
• Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis. (2021/02/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis. (2021/02/03) ♡
• A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy. (2021/02/01) ♡
• Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis. (2021/02/01) ♡
• Amyloidosis and cardiovascular diseases: A clinical insight. (2021/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data. (2021/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exercise-induced mitral regurgitation and right ventricle to pulmonary circulation uncoupling across the heart failure phenotypes. (2021/02/01) ♡
• Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. (2021/02/01) ♡
• AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival. (2021/02/01) ♡
• Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis. (2021/02/01) ♡
• Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis. (2021/01/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction. (2021/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. (2021/01/01) ♡
• [Prognostic factors in light-chain cardiac amyloidosis: a retrospective analysis]. (2021/01/01) ♡
• Tissue Characterization in Cardiology: Moving Beyond Function. (2021/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology (2021-12-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Carpal Tunnel Syndrome and Amyloid Cardiomyopathy (2021-12-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure (2021-12-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis Screening at Trigger Finger Release (2021-12-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Screening for Systemic Amyloidosis Via the Ligamentum Flavum (2021-12-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. HEAR Registry, Healthcare European Amyloidosis Registry (2021-11-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Autonomic Evaluation of Patients With Hereditary Amyloidotic Cardiomyopathy: Hereditary Amyloidotic Heart Disease (2021-10-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome (2021-10-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exercise Effect on Transthyretin Stability (2021-08-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy (2021-08-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis (2021-07-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis (2021-07-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients (2021-07-15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac Amyloidosis (2021-07-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence and Prognosis of Cardiac Amyloidosis in Turkey (2021-06-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) (2021-05-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study (2021-05-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot (2021-03-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transthyretin Cardiac Amyloidosis in HFpEF (2021-03-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Unmasking the Prevalence of AC in an Unselected Echocardiographic Population (2021-02-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy (2021-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy (2021-01-05) ♡
• Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly. (2020/12/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic and prognostic value of cardiac imaging in amyloidosis. (2020/12/26) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.